Biological company Eyenovia launches HYPE treasury reserve strategy, investing $50 million

律动BlockBeats|Jun 17, 2025 19:06

BlockBeats News: On June 18th, according to market reports, Eyenovia, a clinical stage ophthalmic biopharmaceutical company, announced that it will invest $50 million to launch the Hyperliquid (HYPE) treasury reserve strategy.

Mentioned

APP

Windows

Mac

Share To

Facebook

CopyLink

Share To

Timeline

Jul 17, 15:35【Cosmos suspends plans to launch EVM platform】

Jul 17, 14:25【Alchemy Pay investment obtains Hong Kong 1, 4, and 9 licenses】

Jul 17, 13:52【Wolkan Company launches Bitcoin financial strategy】

Jul 17, 12:41【ETH worth 16700, insiders find new method】

Jul 17, 12:34【Uber will invest $300 million to acquire LUCID】

Jul 17, 12:26【LTC micro strategy has been initiated】

Jul 17, 12:00【California Breakthrough Project Launched at Ripple Headquarters】

Jul 17, 11:01【Activate the futures grid robot and receive bonuses】

Jul 17, 10:54【Sequoia Capital AI closed door meeting emphasizes the importance of computing power】

Jul 17, 10:24【Appointing Olha Stefanishyna as the Special Representative of the President of Ukraine】

HotFlash

APP

Windows

Mac

Share To

Facebook

CopyLink

APP

Windows

Mac

Facebook

CopyLink

Biological company Eyenovia launches HYPE treasury reserve strategy, investing $50 million

Timeline

HotFlash

Hot Reads